Literature DB >> 12963146

Anti-inflammatory properties of Bridelia ferruginea stem bark. Inhibition of lipopolysaccaride-induced septic shock and vascular permeability.

Olumayokun A Olajide1, David T Okpako, Janet M Makinde.   

Abstract

The anti-inflammatory activity of the aqueous extract of Bridelia ferruginea stem bark was further evaluated in models which are mediated by tumour necrosis factor-alpha (TNFalpha). The effect of the extract on lipopolysaccharide (LPS)-induced septic shock was evaluated by measuring the number of deaths and the levels of serum alanine and aspartate aminotransferases following intraperitoneal injection of LPS (1 microg/kg) into D-galactosamine-primed mice. LPS-induced vascular permeability on the back skin of mice was measured by the local accumulation of Evan's blue after subcutaneous injection of LPS. Pre-treatment with Bridelia ferruginea extract (10-80 mg/kg) produced a dose-dependent inhibition of the septic shock syndrome in mice, with 80 mg/kg of the extract exhibiting comparable activity as pentoxifylline (100 mg/kg). LPS-induced dye leakage in the skin of mice was also suppressed by the extract (10-80 mg/kg). Our study suggests that one of the mechanisms of the anti-inflammatory effects of Bridelia ferruginea possibly involve the suppression of TNFalpha up-regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12963146     DOI: 10.1016/s0378-8741(03)00219-8

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  2 in total

1.  Bridelia ferruginea Benth.; An ethnomedicinal, phytochemical, pharmacological and toxicological review.

Authors:  Genevieve Naana Yeboah; Frederick William Akuffo Owusu; Mary-Ann Archer; Michael Odoi Kyene; Doris Kumadoh; Frederick Ayertey; Susana Oteng Mintah; Peter Atta-Adjei Junior; Alfred Ampomah Appiah
Journal:  Heliyon       Date:  2022-08-23

2.  Bridelia ferruginea Produces Antineuroinflammatory Activity through Inhibition of Nuclear Factor-kappa B and p38 MAPK Signalling.

Authors:  Olumayokun A Olajide; Mutalib A Aderogba; Uchechukwu P Okorji; Bernd L Fiebich
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-18       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.